Mahon Paul A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Nov 26, 2025
- Accession no.
- 0001231589-25-000011
- Filed
- Nov 26, 2025
- Trade date
- Nov 26, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.35M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahon Paul ACIK 0001231589 | Officer (EVP & GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 26, 2025 | Common Stock | MOption exerciseAcquired | +11,000 | $135.42 | +$1,489,620 | 47,781 | Direct | |
| Nov 26, 2025 | Common Stock | SSaleDisposed | −513 | $483.05F2 | −$247,804.65 | 47,268 | Direct | |
| Nov 26, 2025 | Common Stock | SSaleDisposed | −1,727 | $484.20F3 | −$836,213.4 | 45,541 | Direct | |
| Nov 26, 2025 | Common Stock | SSaleDisposed | −2,210 | $485.15F4 | −$1,072,181.5 | 43,331 | Direct | |
| Nov 26, 2025 | Common Stock | SSaleDisposed | −1,923 | $486.23F5 | −$935,020.29 | 41,408 | Direct | |
| Nov 26, 2025 | Common Stock | SSaleDisposed | −3,350 | $487.21F6 | −$1,632,153.5 | 38,058 | Direct | |
| Nov 26, 2025 | Common Stock | SSaleDisposed | −1,277 | $488.13F7 | −$623,342.01 | 36,781 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 26, 2025 | Common Stock | MOption exerciseDisposed | −11,000 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $482.53 to $483.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $483.71 to $484.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $484.75 to $485.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $485.75 to $486.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $486.76 to $487.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $487.79 to $488.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.